triamcinolone acetonide has been researched along with leuprolide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Dawson-Hughes, B | 1 |
| Ackermann, R; Choi, S; Doty, AC; Feng, MR; Hirota, K; Olsen, KF; Qu, W; Sakamoto, N; Schwendeman, A; Schwendeman, SP; Wang, Y | 1 |
3 other study(ies) available for triamcinolone acetonide and leuprolide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Bone loss accompanying medical therapies.
Topics: Administration, Inhalation; Antineoplastic Agents, Hormonal; Bone Density; Bone Resorption; Diphosphonates; Female; Glucocorticoids; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Osteoporosis; Pamidronate; Prostatic Neoplasms; Triamcinolone Acetonide | 2001 |
Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.
Topics: Animals; Biocompatible Materials; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Gonadotropin-Releasing Hormone; Humans; Injections, Subcutaneous; Kinetics; Lactic Acid; Leuprolide; Male; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Silicon; Solubility; Stainless Steel; Triamcinolone Acetonide; Water | 2016 |